Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Serotonin receptor | Get druggable targets OG5_135430 | All targets in OG5_135430 |
Echinococcus granulosus | hypothetical protein | Get druggable targets OG5_144688 | All targets in OG5_144688 |
Echinococcus multilocularis | conserved hypothetical protein | Get druggable targets OG5_144688 | All targets in OG5_144688 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Thiamine pyrophosphate enzyme, central domain containing protein | 0.0569 | 0.6559 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0325 | 0.3495 | 1 |
Mycobacterium ulcerans | acetolactate synthase 1 catalytic subunit | 0.0569 | 0.6559 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0122 | 0.0927 | 0.1414 |
Mycobacterium tuberculosis | Probable oxidoreductase (beta subunit) | 0.0083 | 0.0438 | 0.0668 |
Leishmania major | phosphonopyruvate decarboxylase-like protein | 0.0184 | 0.1711 | 0.4896 |
Mycobacterium tuberculosis | Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) | 0.0569 | 0.6559 | 1 |
Echinococcus multilocularis | geminin | 0.0177 | 0.1631 | 0.1649 |
Mycobacterium leprae | Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) | 0.0569 | 0.6559 | 1 |
Loa Loa (eye worm) | thiamine pyrophosphate enzyme | 0.0326 | 0.3502 | 0.938 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Giardia lamblia | Pyruvate-flavodoxin oxidoreductase | 0.0083 | 0.0438 | 0.5 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0184 | 0.1711 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0325 | 0.3495 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0184 | 0.1711 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0109 | 0.0774 | 0.0177 |
Treponema pallidum | pyruvate oxidoreductase | 0.0083 | 0.0438 | 0.5 |
Schistosoma mansoni | acetolactate synthase | 0.0486 | 0.5517 | 1 |
Mycobacterium leprae | PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) | 0.0569 | 0.6559 | 1 |
Mycobacterium ulcerans | 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase | 0.0101 | 0.0669 | 0.0378 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0109 | 0.0774 | 0.1179 |
Schistosoma mansoni | acetolactate synthase | 0.0486 | 0.5517 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0184 | 0.1711 | 1 |
Brugia malayi | Serotonin receptor | 0.0564 | 0.6502 | 0.9913 |
Echinococcus granulosus | geminin | 0.0177 | 0.1631 | 0.1631 |
Loa Loa (eye worm) | ILVBL protein | 0.0344 | 0.3733 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.1631 | 0.0738 |
Mycobacterium ulcerans | hypothetical protein | 0.0184 | 0.1711 | 0.208 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0184 | 0.1711 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.1631 | 0.0738 |
Mycobacterium tuberculosis | Probable oxalyl-CoA decarboxylase OxcA | 0.0569 | 0.6559 | 1 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Leishmania major | putative pyruvate/indole-pyruvate carboxylase, putative | 0.0325 | 0.3495 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0122 | 0.0927 | 0.1414 |
Mycobacterium ulcerans | pyruvate or indole-3-pyruvate decarboxylase Pdc | 0.0325 | 0.3495 | 0.4994 |
Mycobacterium ulcerans | hypothetical protein | 0.0569 | 0.6559 | 1 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Mycobacterium ulcerans | putative oxalyl-CoA decarboxylase | 0.0569 | 0.6559 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0109 | 0.0774 | 0.1179 |
Entamoeba histolytica | pyruvate:ferredoxin oxidoreductase | 0.0083 | 0.0438 | 0.5 |
Mycobacterium tuberculosis | Probable reductase | 0.0109 | 0.0774 | 0.1179 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0109 | 0.0774 | 0.1179 |
Mycobacterium ulcerans | acetolactate synthase | 0.0325 | 0.3495 | 0.4994 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0122 | 0.0927 | 0.1414 |
Echinococcus multilocularis | conserved hypothetical protein | 0.0833 | 0.9892 | 1 |
Mycobacterium tuberculosis | Acetolactate synthase (large subunit) IlvB1 (acetohydroxy-acid synthase) | 0.0243 | 0.246 | 0.3751 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0109 | 0.0774 | 0.1179 |
Toxoplasma gondii | thioredoxin reductase | 0.0048 | 0 | 0.5 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Trichomonas vaginalis | pyruvate-flavodoxin oxidoreductase, putative | 0.0083 | 0.0438 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase large subunit IlvB | 0.0325 | 0.3495 | 0.4994 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0122 | 0.0927 | 0.0438 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0109 | 0.0774 | 0.1179 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 63 nM | Agonist activity at human recombinant 5HT2A receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay | ChEMBL. | 21146986 |
EC50 (functional) | = 211 nM | Agonist activity at human recombinant 5HT2C receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay | ChEMBL. | 21146986 |
EC50 (functional) | = 1478 nM | Agonist activity at human recombinant 5HT2B receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay | ChEMBL. | 21146986 |
Emax (functional) | = 73 % | Agonist activity at human recombinant 5HT2B receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay relative to 5-HT | ChEMBL. | 21146986 |
Emax (functional) | = 94 % | Agonist activity at human recombinant 5HT2A receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay relative to 5-HT | ChEMBL. | 21146986 |
Emax (functional) | = 99 % | Agonist activity at human recombinant 5HT2C receptor expressed in CHOK1 cells assessed as induction of intracellular calcium release by FLIPR assay relative to 5-HT | ChEMBL. | 21146986 |
Inhibition (binding) | Inhibition of human ERG expressed in CHO cells at 10 uM by whole cell patch-clamp technique | ChEMBL. | 21146986 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.